Artelo Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARTL and other ETFs, options, and stocks.

About ARTL

Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. 

CEO
Gregory D. Gorgas
CEOGregory D. Gorgas
Employees
6
Employees6
Headquarters
Solana Beach, California
HeadquartersSolana Beach, California
Founded
2011
Founded2011
Employees
6
Employees6

ARTL Key Statistics

Market cap
9.78M
Market cap9.78M
Price-Earnings ratio
-4.78
Price-Earnings ratio-4.78
Dividend yield
—
Dividend yield—
Average volume
3.54M
Average volume3.54M
High today
$14.65
High today$14.65
Low today
$14.42
Low today$14.42
Open price
$21.56
Open price$21.56
Volume
15.03K
Volume15.03K
52 Week high
$25.58
52 Week high$25.58
52 Week low
$4.92
52 Week low$4.92

People also own

Based on the portfolios of people who own ARTL. This list is generated using Robinhood data, and it’s not a recommendation.
SNDL
Tilray Brands
Castor Maritime
Cenntro Inc.
NIO
Robin Energy
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.